Keymed Biosciences (HKSE:02162) FCF Yield % : -6.89 (As of May. 15, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Keymed Biosciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Keymed Biosciences's Trailing 12-Month Free Cash Flow is HK$-750.6 Mil, and Market Cap is HK$10,898.2 Mil. Therefore, Keymed Biosciences's FCF Yield % for today is -6.89%.

The historical rank and industry rank for Keymed Biosciences's FCF Yield % or its related term are showing as below:

HKSE:02162' s FCF Yield % Range Over the Past 10 Years
Min: -15.53 Med: -7.03 Max: -3.77
Current: -6.89

During the past 5 years, the highest FCF Yield % of Keymed Biosciences was -3.77%. The lowest was -15.53%. And the median was -7.03%.

HKSE:02162's FCF Yield % is ranked better than
64.86% of 1554 companies
in the Biotechnology industry
Industry Median: -14.48 vs HKSE:02162: -6.89

Keymed Biosciences's FCF Margin % for the quarter that ended in Dec. 2023 was -1,580.17%.

Keymed Biosciences FCF Yield % Historical Data

The historical data trend for Keymed Biosciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Keymed Biosciences FCF Yield % Chart

Keymed Biosciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-4.95

-5.38

-5.53

Keymed Biosciences Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial				-7.34	-8.96	-5.19	-5.03	-6.86

Competitive Comparison of Keymed Biosciences's FCF Yield %

For the Biotechnology subindustry, Keymed Biosciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Keymed Biosciences's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Keymed Biosciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Keymed Biosciences's FCF Yield % falls into.

Keymed Biosciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Keymed Biosciences's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-750.584	/	13581.2564
	=	-5.53%

Keymed Biosciences's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-466.149	*	2	/	13581.2564
	=	-6.86%

Keymed Biosciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Keymed Biosciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of Keymed Biosciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Keymed Biosciences (HKSE:02162) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Keymed Biosciences Inc (HKSE:02162) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

64Z:Germany

Address

No. 18 BioTown Middle Road, Building D2, Tianfu International BioTown, Chengdu, Sichuan, CHN, 610219

Website

https://www.keymedbio.com

Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of innovative biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. The Group is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment. Geographically, it operates in Hong Kong & Mainland China, out of which the majority is from Mainland China.

Keymed Biosciences (HKSE:02162) Headlines

No Headlines